BNCT’s Advanced Research.
Many studies have been made so far for cancer research, many treatments have been established, however there is no treatment today that is effective in all cancers. Research and development of new therapies is underway all over the world.
The ultra-selective therapy from BNCT, targeting only cancer cells is the most advanced technology today that will selectively destroy even very small cancer cells without damaging the surrounding healthy tissue.
BNCT's radiation therapy with heavy ion and proton beam as a treatment for cancer is still limited because of the initial investment cost of the equipment and the requirement of a larger facility. This is the difficulty we are encountering for the dissemination of this technology. The benefits for the patient however will very quickly help to overcome this initial difficulty.
BNCT's radiation therapy offers new possibilities to treat cancer without the repeated radiations over a large number of zones. This results in much less physical and psychological damage for cancer patients, placing them in a much more positive attitude and preserving their physical and mental health for the treatment.
BNCT also has an unlimited potential with the development of drug delivery systems and with his next generation of cancer treatment. This is how we will continue developing our efforts in good faith towards the future dissemination of our advanced technology.
Mr. Nagatoshi Kadode, President and CEO,
Rerise Medical Systems Co., Ltd.
BNCT in Clinical Trials